Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine-Reference-Cited by-同舟云学术

Fimasartan increases glucose‐stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine

Published:2018-04-06 Issue:7 Volume:20 Page:1670-1677
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Yang Ye Seul¹^ORCID,Lim Min Hyuk²^ORCID,Lee Seong Ok¹,Roh Eun¹^ORCID,Ahn Chang Ho¹,Kwak Soo Heon¹^ORCID,Cho Young Min¹^ORCID,Kim Sungwan²^ORCID,Mari Andrea³,Park Kyong Soo¹⁴,Jung Hye Seung¹⁴^ORCID

Affiliation:

1. Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea

2. Departments of Biomedical Engineering Seoul National University College of Medicine Seoul Republic of Korea

3. Institute of Neuroscience, National Research Council Padova Italy

4. Innovative Research Institute for Cell Therapy, Seoul National University Hospital Seoul Republic of Korea

Funder

Boryung Pharmaceutical Co., Ltd., Republic of Korea

Innovative Research Institute for Cell Therapy of the Ministry of Health and Welfare, Republic of Korea

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13282

Reference36 articles.

1. The renin–angiotensin–aldosterone system, glucose metabolism and diabetes

2. Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study

3. 10. Microvascular Complications and Foot Care

4. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fimasartan Ameliorates Deteriorations in Glucose Metabolism in a High Glucose State by Regulating Skeletal Muscle and Liver Cells;Yonsei Medical Journal;2022

2. Glucagon in type 1 diabetes patients receiving SGLT2 inhibitors: A Friend or Foe?;Diabetes/Metabolism Research and Reviews;2020-10-21

3. Annual decline in β ‐cell function in patients with type 2 diabetes in China;Diabetes/Metabolism Research and Reviews;2020-07

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers

;Drug Design, Development and Therapy;2020-05

5. The association of calcium channel blockers with β‐cell function in type 2 diabetic patients: A cross‐sectional study;The Journal of Clinical Hypertension;2019-03-22